Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Brian C. Vanderplas is active.

Publication


Featured researches published by Brian C. Vanderplas.


Tetrahedron-asymmetry | 1999

The preparation of β-substituted amines from mixtures of epoxide opening products via a common aziridinium ion intermediate

Shelby R. Anderson; Joshua T. Ayers; Keith Michael Devries; Fumitaka Ito; Debra Mendenhall; Brian C. Vanderplas

Abstract Here we describe a one-pot synthesis of a series of β-substituted amines as single enantiomers from an initial regioisomeric mixture of styrene oxide ring-opening products. We also report the isolation and characterization of a key β-chloro intermediate and provide additional insight into the mechanism of the reported alkylations. These results require that the reaction proceeds through a common aziridinium ion intermediate on two separate occasions in order to account for the observed overall net retention of configuration in proceeding from ( S )-styrene oxide to the desired β-substituted amine products.


Tetrahedron-asymmetry | 2003

Efficient synthesis of the κ-opioid receptor agonist CJ-15,161: four stereospecific inversions at a single aziridinium stereogenic center

Michel Couturier; John L. Tucker; Brian M. Andresen; Keith Michael Devries; Brian C. Vanderplas; Fumitaka Ito

Abstract An efficient four-step sequence has been developed for the synthesis of the κ-opioid receptor agonist CJ-15,161. The process features four consecutive regioselective and stereospecific inversions at a single aziridinium stereogenic center, which leads to overall retention of stereochemistry, in a single operation. The chemistry is straightforward, practical and amenable to large-scale synthesis.


Tetrahedron-asymmetry | 1995

Synthesis of an optically active octahydro-2H-pyrido[1,2-a]pyrazine based CNS agent

Frank J. Urban; Ralph Breitenbach; Charles W. Murtiashaw; Brian C. Vanderplas

Abstract A synthesis of an optically active octahydro-2H-pyrido[1,2-a]pyrazine is presented. The key sequence involved the equilibration of an optically active cis-aldehyde to give the thermodynamic trans-aldehyde that was trapped by nitromethane anion.


Tetrahedron Letters | 2001

Oxidation of carbamate-protected alkylhydrazines to the corresponding hydrazones under Swern conditions

Joseph Dupont; Raymond J. Bemish; Keith E. McCarthy; Emily R. Payne; Ernest B. Pollard; David H. Brown Ripin; Brian C. Vanderplas; Richard M. Watrous

Abstract Carbamate protected alkylhydrazines have been found to oxidize cleanly to the corresponding hydrazone under Swern conditions. The reaction works on hydrazines with primary, secondary, and branched alkyl groups.


Organic Process Research & Development | 2014

Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin

Paul Bowles; Steven J. Brenek; Stephane Caron; Nga M. Do; Michele T. Drexler; Shengquan Duan; Pascal Dubé; Eric C. Hansen; Brian P. Jones; Kris Nicole Jones; Tomislav A. Ljubicic; Teresa W. Makowski; Jason Mustakis; Jade D. Nelson; Mark Olivier; Zhihui Peng; Hahdi H. Perfect; David William Place; John A. Ragan; John J. Salisbury; Corey L. Stanchina; Brian C. Vanderplas; Mark E. Webster; R. Matt Weekly


Organic Process Research & Development | 2003

Safe Execution of a Large-Scale Ozonolysis: Preparation of the Bisulfite Adduct of 2-Hydroxyindan-2-carboxaldehyde and Its Utility in a Reductive Amination

John A. Ragan; David J. am Ende; Steven J. Brenek; Shane Allen Eisenbeis; Robert A. Singer; Derek L. Tickner; John J. Teixeira; Brian C. Vanderplas; Neil Philip Weston


Tetrahedron | 2009

Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity

Thomas A. Brandt; Stephane Caron; David B. Damon; Joseph DiBrino; Arun Ghosh; David A. Griffith; Sandeep Kedia; John A. Ragan; Peter Robert Rose; Brian C. Vanderplas; Lulin Wei


Organic Syntheses | 2009

Large Scale, Green Synthesis of a Generation‐1 Melamine (Triazine) Dendrimer

Abdellatif Chouai; Vincent J. Venditto; Eric E. Simanek; Brian C. Vanderplas; John A. Ragan


Organic Process Research & Development | 2009

Development of a Practical and Efficient Synthesis of CP-945,598-01, a CB1 Antagonist for the Treatment of Obesity

John A. Ragan; Dennis E. Bourassa; Jon Blunt; Darragh Breen; Frank Robert Busch; Eric M. Cordi; David B. Damon; Nga M. Do; Alanya Engtrakul; Denis Lynch; Ruth E. McDermott; Joseph A. Mongillo; Maria M. O’Sullivan; Peter Robert Rose; Brian C. Vanderplas


Chimia | 2006

Process research and scale-up of the κ-opioid receptor agonist CJ-15,161 drug candidate

Brian M. Andresen; Stephane Caron; Michel Couturier; Keith Michael Devries; Nga M. Do; Kristina Dupont-Gaudet; Arun Ghosh; Melina Girardin; Joel M. Hawkins; Teresa Margaret Makowski; Maxime Riou; Janice E. Sieser; John L. Tucker; Brian C. Vanderplas; Timothy J. N. Watson

Collaboration


Dive into the Brian C. Vanderplas's collaboration.

Researchain Logo
Decentralizing Knowledge